Saverio Minucci

DIRECTOR

Chromatin Alterations in Tumorigenesis Unit

+39 02.57489.832

+39 02.94375.990

Email segreteria

Publications

Publications
- THALER F, VARASI M, ABATE A, CARENZI G, COLOMBO A, BIGOGNO C, BOGGIO R, DAL ZUFFO R, RAPETTI D, RESCONI A, REGALIA N, VULTAGGIO S, DONDIO G, GAGLIARDI S, MINUCCI S, MERCURIO C (2013). Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitors. European journal of medicinal chemistry 04/2013; 64C:273-284.
- SANTORO F, BOTRUGNO OA, DAL ZUFFO R, PALLAVICINI I, MATTHEWS GM, CLUSE L, BAROZZI I, SENESE S, FORNASARI L, MORETTI S, ALTUCCI S, PELICCI PG, CHIOCCA S, JOHNSTONE RW, MINUCCI S (2013). A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. Blood, 121 (17): 3459-68. doi:10.1182/blood-2012-10-461988
- SONCINI M, SANTORO F, GUTIERREZ A, FRIGÈ G, ROMANENGHI M, BOTRUGNO OA, PALLAVICINI I, PELICCI P, DI CROCE L, MINUCCI S (2013). The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemia. BIOCHIMICA ET BIOPHYSICA ACTA, 1832 (1): 114-20. ISSN: 0006-3002
- KLIONSKY DJ et al. (2012). Guidelines for the use and interpretation of assays for monitoring autophagy.Autophagy, 8: 4, 445-544, April 2012.
- SAEED S, LOGIE C, FRANCOIJS KJ, FRIGÈ G, ROMANENGHI M, NIELSEN FG, RAATS L, SHAHHOSEINI M, HUYNEN M, ALTUCCI L, MINUCCI S, MARTENS JH, STUNNENBERG HG (2012). Chromatin accessibility, p300 and histone acetylation define PML-RARa and AML1-ETO binding sites in acute myeloid leukemia. BLOOD, vol. 120, p. 3058-3068, ISSN: 0006-4971